dev.PILOTforPulmonary.orgdev.PILOTforPulmonary.orgdev.PILOTforPulmonary.org

 x 

0 Activities
0 Activities
  • No Saved Activities
  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar

    Search Education

    Latest Education

    No image set

    A Collaborative Approach to IPF Management

    No image set

    Practical Solutions to SSc-ILD Treatment

    No image set

    Post COVID-19 and Patients With and Without Pre-existing ILD

    Menu Ad
  • Register
  • Contact Us
  • Login

    Login

    Create an account
    • Forgot your password?
  • Start
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • »
  • End
Page 3 of 8
Results 31 - 45 of 114
9165 pneumo explore
Utilizing ACIP's Updated Pneumococcal Recommendations
9078_DMD-icon9
DMD and Gene Therapy: What's on the Horizon?
9155-cart-cell
CAR T-Cell Therapy Consults: Navigating a New Landscape
9167-0001-263x149
Treating Persistent/Chronic ITP: Current Care, Future Potential
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
No image set
Updates in Duchenne Muscular Dystrophy: A Focus on Emerging Gene Therapy
No image set
EXPLORE Learning Experience: COVID-19 and Monoclonal Antibodies
No image set
EXPLORE Learning Experience: Understanding and Managing NTM-Lung Disease
No image set
Cardiac Amyloidosis: Is It A Zebra or A Horse? Webinar Summary Module
No image set
A New Paradigm in Treating ILD
No image set
How to Choose the Right Therapy for Your Patients with IPF
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
  • Start
  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • »
  • End
Page 3 of 8

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Copyright © 2024 The France Foundation All Rights Reserved.
The France Foundation | Privacy Policy | Terms of Use

Search

  • Home
  • Education
    • Top Disease Areas
      • Asthma
      • Bronchiectasis
      • Chronic Obstructive Pulmonary Disease (COPD)
      • COVID-19
      • Idiopathic Pulmonary Fibrosis
      • Interstitial Lung Disease (ILD)
      • Nontuberculous Mycobacteria (NTM)
      • Non-Small Cell Lung Cancer (NSCLC)
      • Pulmonary Hypertension (PH/PAH)
      • Radiology
      • Rheumatoid Conditions
    • Content Type
      • Animation
      • EXPLORE™
      • Interactive Cases
      • Podcast
      • Slides
      • Video
      • Webinar
  • Register
  • Contact Us
  • Login
This site uses cookies. By continuing to use this website, you agree to their use. For details, please check our Privacy Policy.
I accept